First Republic Investment Management Inc. lifted its stake in shares of Davis Select U.S. Equity ETF (NASDAQ:DUSA) by 11.9% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 20,090 shares of the healthcare company’s stock after buying an additional 2,137 shares during the quarter. First Republic Investment Management Inc. owned about 0.24% of Davis Select U.S. Equity ETF worth $471,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Howard Financial Services LTD. bought a new position in Davis Select U.S. Equity ETF during the second quarter valued at approximately $468,000. CWM LLC purchased a new stake in shares of Davis Select U.S. Equity ETF in the second quarter worth $56,000. Steward Partners Investment Advisory LLC purchased a new stake in shares of Davis Select U.S. Equity ETF in the second quarter worth $119,000. Finally, Stratos Wealth Partners LTD. grew its stake in Davis Select U.S. Equity ETF by 64.1% during the first quarter. Stratos Wealth Partners LTD. now owns 46,907 shares of the healthcare company’s stock valued at $1,059,000 after acquiring an additional 18,315 shares in the last quarter.
DUSA traded up $0.04 during trading on Friday, hitting $24.35. 1,200 shares of the company traded hands, compared to its average volume of 14,556. Davis Select U.S. Equity ETF has a 1 year low of $18.76 and a 1 year high of $26.54. The stock’s 50-day simple moving average is $23.39 and its two-hundred day simple moving average is $23.22.
Davis Select U.S. Equity ETF Company Profile
DUSA Pharmaceuticals, Inc (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company’s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp.
Further Reading: When can a hold rating present a buying opportunity?
Receive News & Ratings for Davis Select U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.